EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL

Rudolf A Werner iD, Bilêl Habacha, Susanne Lütje, Lena Bundschuh, Takahiro Higuchi iD, Philipp Hartrampf, Sebastian E Serfling, Thorsten Derlin iD, Constantin Lapa, Andreas K Buck, Markus Essler, Kenneth J Pienta und 10 weitere

Molecular Imaging · 2022-01 · 2022

DOI: 10.1155/2022/7056983 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Molecular Imaging, online erschienen am 23.02.2022. Verfasst von Rudolf A Werner und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NCI NIH HHS, Progenics Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In patients with prostate cancer (PC) receiving prostate-specific membrane antigen- (PSMA-) targeted radioligand therapy (RLT), higher baseline standardized uptake values (SUVs) are linked to improved outcome. Thus, readers deciding on RLT must have certainty on the repeatability of PSMA uptake metrics. As such, we aimed to evaluate the test-retest repeatability of lesion uptake in a large cohort of patients imaged with 18 F-DCFPyL.

Methods

In this prospective, IRB-approved trial ( NCT03793543 ), 21 patients with history of histologically proven PC underwent two 18 F-DCFPyL PET/CTs within 7 days (mean 3.7, range 1 to 7 days). Lesions in the bone, lymph nodes (LN), and other organs were manually segmented on both scans, and uptake parameters were assessed (maximum (SUV max ) and mean (SUV mean ) SUVs), PSMA-tumor volume (PSMA-TV), and total lesion PSMA (TL-PSMA, defined as [Formula: see text])). Repeatability was determined using Pearson’s correlations, within-subject coefficient of variation (wCOV), and Bland-Altman analysis.

Results

In total, 230 pairs of lesions (177 bone, 38 LN, and 15 other) were delineated, demonstrating a wide range of SUV max (1.5–80.5) and SUV mean (1.4–24.8). Including all sites of suspected disease, SUVs had a strong interscan correlation ([Formula: see text]), with high repeatability for SUV mean and SUV max (wCOV, 7.3% and 12.1%, respectively). High SUVs showed significantly improved wCOV relative to lower SUVs ([Formula: see text]), indicating that high SUVs are more repeatable, relative to the magnitude of the underlying SUV. Repeatability for PSMA-TV and TL-PSMA, however, was low ([Formula: see text]%). Across all metrics for LN and bone lesions, interscan correlation was again strong ([Formula: see text]). Moreover, LN-based SUV mean also achieved the best wCOV (3.8%), which was significantly reduced when compared to osseous lesions (7.8%, [Formula: see text]). This was also noted for SUV max (wCOV, LN 8.8% vs. bone 12.0%, [Formula: see text]). On a compartment-based level, wCOVs for volumetric features were ≥22.8%, demonstrating no significant differences between LN and bone lesions (PSMA-TV, P =0.63; TL-PSMA, P =0.9). Findings on an entire tumor burden level were also corroborated in a hottest lesion analysis investigating the SUV max of the most intense lesion per patient ([Formula: see text], 0.99; wCOV, 11.2%).

Conclusion

In this prospective test-retest setting, SUV parameters demonstrated high repeatability, in particular in LNs, while volumetric parameters demonstrated low repeatability. Further, the large number of lesions and wide distribution of SUVs included in this analysis allowed for the demonstration of a dependence of repeatability on SUV, with higher SUVs having more robust repeatability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsHumansMaleProspective StudiesTumor Burden

Autor:innen und Institutionen

  • Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Comprehensive Heart Failure Center University Hospital Würzburg, Würzburg, Germany.
  • Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
  • Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Medical School Hannover, Department of Nuclear Medicine, Hannover, Germany.
  • Nuclear Medicine, Medical Faculty, University of Augsburg, Germany.

ORCID-Profile: Rudolf A Werner, Takahiro Higuchi, Thorsten Derlin, Steven P Rowe

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • Progenics Pharmaceuticals
  • KAKENHI
  • HiLF
  • Prostate Cancer Foundation Young Investigator Award, Movember Foundation, and National Institutes of Health

Zitieren

APA

Werner, R. A., Habacha, B., Lütje, S., Bundschuh, L., Higuchi, T., Hartrampf, P., Serfling, S. E., Derlin, T., Lapa, C., Buck, A. K., Essler, M., Pienta, K. J., Eisenberger, M. A., Markowski, M. C., Shinehouse, L., AbdAllah, R., Salavati, A., Lodge, M. A., Pomper, M. G., …, & Rowe, S. P. (2022). High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL. Molecular Imaging, 2022. https://doi.org/10.1155/2022/7056983

Vancouver

Werner RA, Habacha B, Lütje S, Bundschuh L, Higuchi T, Hartrampf P, et al. High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL. Molecular Imaging. 2022;2022. doi:10.1155/2022/7056983

BibTeX
@article{Werner2022,
  author = {Werner, Rudolf A and Habacha, Bilêl and Lütje, Susanne and Bundschuh, Lena and Higuchi, Takahiro and Hartrampf, Philipp and Serfling, Sebastian E and Derlin, Thorsten and Lapa, Constantin and Buck, Andreas K and Essler, Markus and Pienta, Kenneth J and Eisenberger, Mario A and Markowski, Mark C and Shinehouse, Laura and AbdAllah, Rehab and Salavati, Ali and Lodge, Martin A and Pomper, Martin G and Gorin, Michael A and Bundschuh, Ralph A and Rowe, Steven P},
  title = {High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18 F-DCFPyL},
  journal = {Molecular Imaging},
  year = {2022},
  volume = {2022},
  doi = {10.1155/2022/7056983}
}
Kostenlos starten →